Benlysta 200 MG/ML autoinjectml
Ended Awarded
- Contract number
- SPE2DB25FWJVM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,083
Award facts
- Contract value 100% obligated
- $3,082.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on August 5, 2025, with completion targeted for August 26, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement utilizing the company's existing Indefinite Delivery Contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting federal medical supply requirements through the Defense Logistics Agency's distribution network.
This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive $999.999 billion Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. Benlysta (belimumab) is a biologic medication used in the treatment of systemic lupus erythematosus and other autoimmune conditions, representing the specialized pharmaceutical products within the company's broad portfolio of brand-name drugs, generics, vaccines, and medical supplies provided to defense and veteran healthcare systems. AmerisourceBergen's role as a prime pharmaceutical vendor demonstrates its capability to fulfill critical federal medical procurement requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FWJVM?
SPE2DB25FWJVM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FWJVM worth?
The government has obligated $3,083 on SPE2DB25FWJVM.
Is contract SPE2DB25FWJVM an order under another contract?
Yes. SPE2DB25FWJVM is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWJVM competed?
The extent of competition for SPE2DB25FWJVM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award